Application of stem cell transplantation in kidney diseases
HUANG Dan-Lin, YI Zhu-Wen
Division of Pediatric Nephrology, Department of Pediatrics, Second Xiangya Hospital of Central South University, Changsha 410011, China. yizhuwen@yahoo.com.cn
Abstract:This paper summarizes the current literature on the potential therapeutic role of stem cell transplantation for kidney injury and repair and focuses on the choice of types of stem cells, the method of transplantation, and the mechanisms of stem cell homing to injured renal tissues and its protective effects. The application of umbilical cord mesenchymal stem cells (UC-MSCs) shows wide prospects, but the approach and optimal dose of cell transplantation are under intensive investigation. Signals that regulate stem cell homing to injured renal tissues may be related to chemokines or factors released in the target site. Several studies have pointed out that paracrine and endocrine of stem cells are the most likely mechanism of action in the injured nephron. Many questions remain unanswered but stem cell-based therapy is a promising new strategy for acute and chronic kidney diseases.
[1]Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts[J]. Science, 1998, 282(5391): 1145-1147.
[2]Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney[J]. J Clin Invest, 2005, 115(7): 1756-1764.
[3]Bussolati B, Bruno S, Grange C, Buttiglieri S, Chiara DM, Cantino D, et al. Isolation of renal progenitor cells from adult human kidney[J]. Am J Pathol, 2005, 166(2): 545-555.
[4]Lazzeri E, Crescioli C, Ronconi E, Mazzinghi B, Sagrinati C, Netti GS, et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure[J]. J Am Soc Nephrol, 2007, 18(12): 3128-3138.
[5]Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells[J]. J Exp Med, 2008, 205(2): 479-490.
[10]Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney[J]. J Clin Invest, 2005, 115(7): 1756-1764.
[11]Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure[J]. J Am Soc Nephrol, 2004, 15(7): 1794-1804.
[17]Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood[J]. Br J Haematol, 2000, 109(1): 235-242.
[18]Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials[J]. Haematologica, 2006, 91(8): 1017-1026.
[20]Caballero M, Reed CR, Madan G, van AJA. Osteoinduction in umbilical cord-and palate periosteumderived mesenchymal stem cells[J]. Ann Plast Surg, 2010, 64(5): 605-609.
[21]Zhang HT, Chen H, Zhao H, Dai YW, Xu RX. Neural stem cells differentiation ability of human umbilical cord mesenchymal stromal cells is not altered by cryopreservation[J]. Neurosci Lett, 2011, 487(1): 118-122.
[23]Cao H, Qian H, Xu W, Zhu W, Zhang X, Chen Y, et al. Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats[J]. Biotechnol Lett, 2010, 32(5): 725732.
[24]Chen Y, Qian H, Zhu W, Zhang X, Yan Y, Ye S, et al. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury[J]. Stem Cells Dev, 2011, 20(1): 103-113.
[25]Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, et al. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice[J]. Lupus, 2010, 19(13): 1502-1514.
[26]Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663-676.
[27]Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells[J]. Science, 2008, 321(5889): 699-702.
[28]Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J]. Cell, 2007, 131(5): 861-872.
[29]Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells[J]. Curr Biol, 2008, 18(12): 890-894.
[30]Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood[J]. Blood, 2009, 113(22): 5476-5479.
[31]Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells[J]. Circ Res, 2009, 104(4): e30-e41.
[32]Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons[J]. Stem Cells, 2009, 27(4): 806-811.
[33]Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells[J]. Stem Cells, 2009, 27(3): 559567.
[34]Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells[J]. Neurosci Lett, 2009, 458(3): 126-131.
[35]Rossant J. Stem cells: the magic brew[J]. Nature, 2007, 448(7151): 260-262.
[36]Kunter U, Rong S, Boor P, Eitner F, MullerNewen G, Djuric Z, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes[J]. J Am Soc Nephrol, 2007, 18(6): 1754-1764.
[37]Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice[J]. Stem Cells, 2008, 26(8): 2075-2082.
[38]Quimby JM, Webb TL, Gibbons DS, Dow SW. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study[J]. J Feline Med Surg, 2011,13(6): 418-426.
[39]Rogers SA, Hammerman MR. Transplantation of rat metanephroi into mice[J]. Am J Physiol Regul Integr Comp Physiol, 2001, 280(6): R1865-R1869.
[46]Yoo JH, Park C, Jung DI, Lim CY, Kang BT, Kim JH, et al. In vivo cell tracking of canine allogenic mesenchymal stem cells administration via renal arterial catheterization and physiopathological effects on the kidney in two healthy dogs[J]. J Vet Med Sci, 2011, 73(2):268-274.
[47]Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis[J]. J Am Soc Nephrol, 2006, 17(8): 22022212.
[51]Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice[J]. Cell Mol Immunol, 2008, 5(6): 417-424.
[52]Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury[J]. Stem Cells Dev, 2009, 18(3): 475-485.
[53]Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure[J]. Stem Cells Dev, 2009, 18(3): 521-529.
[54]Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice[J]. Biol Blood Marrow Transplant, 2008, 14(6): 631-640.
[55]Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, et al. Mesenchymal stem cells are capable of homing to the bone marrow of nonhuman primates following systemic infusion[J]. Exp Hematol, 2001, 29(2): 244-255.
[56]Behr L, Hekmati M, Lucchini A, Houcinet K, Faussat AM, Borenstein N, et al. Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury[J]. Cell Prolif, 2009, 42(3): 284-297.
[57]Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy[J]. J Clin Oncol, 2000, 18(2): 307-316.
[59]Bentzon JF, Stenderup K, Hansen FD, Schroder HD, Abdallah BM, Jensen TG, et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene[J]. Biochem Biophys Res Commun, 2005, 330(3): 633-640.
[60]Zhang W, Qin C, Zhou ZM. Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model[J]. Transplant Proc, 2007, 39(10): 3404-3408.
[61]Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia dos Reis M, Shimizu MH, et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model[J]. Stem Cells, 2009, 27(12): 3063-3073.
[62]Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury[J]. Kidney Int, 2007, 72(4): 430-441.
[63]Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury[J]. Annu Rev Med, 2008, 59: 311-325.